肝素诱导的血小板缩:一种罕见的表现,伴有皮肤缩
Filipa David1, Ana Catarina Trigo1, José Ribeiro1
1Internal Medicine Service, Medical Department, Hospital Pedro Hispano, Matosinhos, Portugal.
Dermatology reports
|December 5, 2024
概括
氨酸诱导的血小板缺血 (HIT) 是氨酸治疗的严重并发症. 这一案例突出显示HIT呈皮肤亡,强调迅速停止肝素和替换抗凝剂.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝素诱导的血小板缺血症 (HIT) 是一种原血小板免疫疾病.
- 它是由抗血小板因子4 (PF4) /肝素复合体的抗体触发的.
- HIT导致血小板激活,聚合和消耗,导致血小板缺血和血栓形成.
研究的目的:
- 报告一种罕见的HIT病例,这种病例呈皮肤死.
- 为了强调认识到这一演示的关键重要性.
- 强调立即停止使用肝素和替代抗凝药的必要性.
主要方法:
- 案例报告的呈现方式.
- 对HIT的临床表现和诊断考虑的审查.
- 讨论HIT的管理策略.
主要成果:
- 患者出现了皮肤亡,这是HIT的罕见表现.
- 血栓并发症,而不是出血,是HIT的主要问题.
- 及时识别和管理对于患者的治疗结果至关重要.
结论:
- 皮肤亡可能是HIT的初始表现.
- 早期诊断和停止肝素治疗至关重要.
- 替代性抗凝药是必要的,以防止进一步的血栓事件.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616
Disorders of Hemostasis
707
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
707
Introduction to Hemostasis
5.6K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.6K
Extrinsic and Intrinsic Pathways of Hemostasis
5.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.5K
Formation of the Platelet Plug
4.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.4K
Endocarditis II: Clinical features and Diagnostic Tests
1
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
1


